VYNE Therapeutics Inc (VYNE)
2.27
-0.13
(-5.42%)
USD |
NASDAQ |
Apr 18, 16:00
2.27
0.00 (0.00%)
After-Hours: 20:00
VYNE Therapeutics Net Income (TTM): -28.45M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -28.45M |
| September 30, 2023 | -32.21M |
| June 30, 2023 | -35.08M |
| March 31, 2023 | -33.50M |
| December 31, 2022 | -23.21M |
| September 30, 2022 | -24.84M |
| June 30, 2022 | -36.66M |
| March 31, 2022 | -48.11M |
| December 31, 2021 | -73.33M |
| September 30, 2021 | -84.94M |
| June 30, 2021 | -88.37M |
| March 31, 2021 | -235.88M |
| December 31, 2020 | -255.57M |
| Date | Value |
|---|---|
| September 30, 2020 | -253.88M |
| June 30, 2020 | -246.03M |
| March 31, 2020 | -95.06M |
| December 31, 2019 | -73.70M |
| September 30, 2019 | -69.80M |
| June 30, 2019 | -65.79M |
| March 31, 2019 | -57.66M |
| December 31, 2018 | -51.44M |
| September 30, 2018 | -43.13M |
| June 30, 2018 | -38.45M |
| March 31, 2018 | -36.26M |
| December 31, 2017 | -29.08M |
| September 30, 2017 | -24.64M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-255.57M
Minimum
Dec 2020
-23.21M
Maximum
Dec 2022
-94.97M
Average
-69.80M
Median
Sep 2019
Net Income (TTM) Benchmarks
| Viking Therapeutics Inc | -85.90M |
| AN2 Therapeutics Inc | -64.73M |
| NovaBay Pharmaceuticals Inc | -9.64M |
| Palatin Technologies Inc | -31.59M |
| iBio Inc | -27.28M |